Stelara (Generic Ustekinumab): Complete Medication Guide
Key Takeaways
Ustekinumab is a biologic medication that suppresses the immune system to reduce inflammation in autoimmune conditions.
It's used to treat plaque psoriasis, psoriatic arthritis, Crohn's disease, and ulcerative colitis.
Common side effects include injection site reactions and upper respiratory infections; serious risks include infections and malignancy.
Dosing is based on body weight and is given as subcutaneous injections every 12 weeks after an initial loading phase.
This information is educational and does not replace advice from your healthcare provider.
Stelara (Generic Ustekinumab) Overview
Ustekinumab, sold under the brand name Stelara, is a monoclonal antibody—a type of biologic medication that works by targeting specific proteins in the immune system. It belongs to a class of drugs called IL-12/IL-23 inhibitors, which means it blocks two immune signaling molecules that drive inflammation. By reducing these signals, ustekinumab helps calm overactive immune responses that cause chronic inflammation in conditions like psoriasis, psoriatic arthritis, Crohn's disease, and ulcerative colitis.
The generic version of ustekinumab offers the same active ingredient as the brand-name Stelara. Generic vs Brand Name Drugs contain identical active ingredients and work the same way in your body, though they may cost significantly less. This makes biologic treatment more accessible to patients who need long-term immune suppression to manage their conditions.
Ustekinumab works by binding to IL-12 and IL-23, proteins that trigger T-cell responses and inflammatory pathways. By blocking these signals, the drug reduces the production of inflammatory cytokines and helps normalize immune function. This mechanism makes it effective for both skin conditions like psoriasis and inflammatory bowel diseases where immune dysfunction plays a central role.
Side Effects
Ustekinumab is generally well-tolerated, though like all immune-suppressing medications, it carries both common and serious risks. Most people experience mild injection site reactions or mild infections, but serious complications—though uncommon—require prompt medical attention.
Common Side Effects
Injection site reactions: Redness, itching, swelling, or pain at the spot where you inject the medication; usually mild and resolves within a few days.
Upper respiratory infections: Increased susceptibility to colds, sore throats, or sinus infections due to immune suppression.
Headache: Mild to moderate head pain that may occur in the first few weeks of treatment.
Fatigue: Feeling unusually tired or lacking energy, particularly early in treatment.
Nausea: Mild stomach upset or queasiness that typically improves with continued use.
Muscle or joint aches: Temporary discomfort in muscles or joints unrelated to your underlying condition.
Serious Side Effects
Serious infections: Bacterial, viral, or fungal infections that may be life-threatening, including tuberculosis reactivation or opportunistic infections.
Malignancy: Increased risk of certain cancers, particularly lymphoma and non-melanoma skin cancers with long-term use.
Reversals of psoriasis: Paradoxical worsening or sudden onset of severe psoriasis or psoriasiform rash (rare but documented).
Anaphylaxis: Severe allergic reaction causing difficulty breathing, throat swelling, or severe rash (extremely rare).
Posterior reversible encephalopathy syndrome (PRES): Rare but serious neurological condition with symptoms like seizures, vision changes, or confusion.
When to Seek Medical Attention
Contact your healthcare provider immediately if you develop signs of infection (fever, chills, persistent cough, or unusual fatigue), unexpected bruising or bleeding, severe headaches, vision changes, or difficulty breathing. Don't wait if you notice a new or worsening rash, symptoms of an allergic reaction, or unexplained weight loss. These symptoms may indicate a serious condition that needs prompt evaluation.
Also reach out to your doctor if common side effects persist for more than a few weeks, worsen despite treatment, or interfere with your daily life. Your clinician can adjust your dose, recommend supportive treatments, or discuss switching medications if needed.
Dosage
Dose Level or Form |
Dose |
Key Detail |
Initial Loading Dose (Psoriasis/Psoriatic Arthritis) |
45 mg or 90 mg |
Based on body weight; <100 kg = 45 mg; ≥100 kg = 90 mg |
Maintenance Dose (Psoriasis/Psoriatic Arthritis) |
45 mg or 90 mg |
Given 4 weeks after initial dose, then every 12 weeks |
Initial Loading Dose (Crohn's/UC) |
Weight-based IV infusion |
Given as one infusion; dose calculated by your clinician |
Maintenance Dose (Crohn's/UC) |
90 mg subcutaneous |
Injected every 8 weeks after initial IV dose |
Dose Adjustment |
Case-by-case |
Your doctor may adjust based on response or side effects |
Important: Never stop taking ustekinumab without consulting your doctor, even if you feel better. Stopping suddenly can cause your condition to flare. If you miss an injection, contact your healthcare provider to reschedule as soon as possible—don't double-dose. Store injections in the refrigerator and allow them to warm to room temperature for 15–30 minutes before injection to reduce discomfort.
Drug Interactions
Ustekinumab, as an immune-suppressing biologic, can interact with other medications that affect immunity or liver function. Always inform your doctor about all medications, supplements, and vaccines you take.
Live Vaccines
Live vaccines (such as MMR, varicella, or rotavirus) should not be given while taking ustekinumab because your immune system may not respond properly and the virus in the vaccine could cause infection. Discuss vaccination timing with your doctor; inactivated vaccines are usually safe.
Other Biologic Medications
Combining ustekinumab with other biologics (like TNF inhibitors or other monoclonal antibodies) increases infection risk significantly and is generally not recommended without careful medical supervision.
Immunosuppressants (Methotrexate, Azathioprine)
Using ustekinumab with other immune-suppressing drugs increases the risk of serious infections, including tuberculosis reactivation and opportunistic infections. Your doctor will weigh benefits against risks carefully.
Medications Metabolized by the Liver (CYP3A4 Inhibitors)
Certain drugs that slow liver metabolism may affect how ustekinumab is processed, though ustekinumab itself is not heavily metabolized. Still, discuss your full medication list with your clinician to ensure safety.
NSAIDs or Corticosteroids
While not direct interactions, combining ustekinumab with NSAIDs or steroids for symptom management is common; however, these may mask infection symptoms, so closer monitoring is needed.
Continue Learning
Related articles you might find helpful
Pros and Cons
Pros
Highly effective for moderate to severe psoriasis: Clinical trials show ustekinumab achieves clear or nearly clear skin in the majority of patients.
Convenient dosing schedule: After initial loading doses, you only need injections every 12 weeks, making it easier to maintain than weekly or monthly treatments.
Helps multiple conditions: Approved for psoriasis, psoriatic arthritis, Crohn's disease, and ulcerative colitis, offering broader disease coverage than some alternatives.
Affordable as a generic: Cost-Effective Alternative to Brand-Name Drugs means you can access this biologic at a fraction of the brand-name Stelara cost.
Self-administered injections: You can inject the medication at home after training, reducing the need for frequent clinic visits.
Cons
Increased infection risk: Immune suppression means you're more susceptible to serious infections, including TB, requiring ongoing monitoring.
Cancer risk: Long-term use increases risk of lymphoma and skin cancers, necessitating regular dermatology visits and cancer screening.
High upfront cost: Even as a generic, ustekinumab is expensive, and insurance coverage varies; many patients need prior authorization.
Slow onset of action: It may take 12–16 weeks to see full benefits, which is longer than some other biologic treatments.
Potential for paradoxical flares: Rare but serious worsening of psoriasis or new rash development requires immediate medical evaluation.
Frequently Asked Questions
Get answers to common questions about generic ustekinumab.
Most people begin to see improvement in their psoriasis or arthritis symptoms within 4–8 weeks, but maximum benefit often takes 12–16 weeks. The timeline varies based on your condition severity and individual response. If you're not seeing improvement after 16 weeks, discuss options with your doctor—you may need a dose adjustment or a different medication.
Yes. Generic vs. Brand-Name Drugs contain the same active ingredient and work identically in your body. The FDA requires generics to have the same purity, strength, and stability as the brand-name version. The main difference is cost—generics are typically 30–50% cheaper.
Do not stop ustekinumab on your own, even if your symptoms clear. Stopping abruptly often leads to disease flares within weeks or months. Talk with your doctor about whether long-term maintenance is right for you or if there's a safe way to pause or taper the medication under medical supervision.
Contact your healthcare provider or pharmacist right away to reschedule your next dose. Missing one injection typically won't cause immediate harm, but delaying doses can reduce effectiveness and increase flare risk. Never inject two doses to make up for a missed one—your doctor will advise when to resume your schedule.
Pregnancy while on ustekinumab requires careful discussion with your doctor. Limited data suggests it may be safe, but risks haven't been fully studied. Your doctor will weigh the benefits of controlling your disease against potential fetal risks. Some patients may pause treatment during pregnancy; others may continue. Never stop without medical guidance.
The Bottom Line
Generic ustekinumab is a powerful biologic medication that effectively controls moderate to severe psoriasis, psoriatic arthritis, Crohn's disease, and ulcerative colitis by suppressing overactive immune responses. While it offers convenient dosing every 12 weeks and significant cost savings as a generic, it requires careful monitoring for serious infections and increased cancer risk. Most people tolerate the medication well, with common side effects being mild injection site reactions or respiratory infections. However, you must be screened for tuberculosis before starting and maintain regular follow-up visits to catch any complications early.
If you're considering ustekinumab or want to discuss whether it's the right choice for your condition, Doctronic can help. As the first AI legally authorized to practice medicine, Doctronic offers free AI consultations and affordable video or text visits with licensed clinicians available 24/7. Get your questions answered and explore treatment options tailored to your needs today.
